Nomura Holdings’s 10x Genomics TXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.64M Sell
77,036
-248,747
-76% -$4.97M ﹤0.01% 990
2025
Q4
$5.31M Buy
+325,783
New +$4.92M 0.01% 746
2023
Q2
Sell
-8,750
Closed -$488K 1640
2023
Q1
$488K Sell
8,750
-57,850
-87% -$2.7M ﹤0.01% 1139
2022
Q4
$2.42M Buy
+66,600
New +$2.18M 0.01% 669

Other funds holding TXG

Nomura Holdings's TXG Position: Q1 2026 in Review

Nomura Holdings reduced its 10x Genomics (TXG) stake by 76% in Q1 2026, selling an estimated $4.97M and leaving 77,036 shares worth $1.64M. The position accounts for ﹤0.01% of the portfolio, ranked #990.

Nomura Holdings first reported a position in TXG in Q4 2022 and has held it in 4 quarters since. The position peaked at $5.31M in Q4 2025. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Nomura Holdings held 77,036 shares of 10x Genomics worth $1.64M as of Q1 2026.
  • Nomura Holdings sold 248,747 10x Genomics shares in Q1 2026, an estimated $4.97M.
  • 10x Genomics made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #990 holding.
  • Nomura Holdings first reported a position in 10x Genomics in Q4 2022 and has held it in 4 quarters since.
  • Nomura Holdings's 10x Genomics position peaked at $5.31M in Q4 2025.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.